FDA has also warned women at elevated risk of cancer based on family history and gene mutation not to use the tests available in the market for screening or making their treatment decisions. They are instead advised to visit their doctor to discuss how to reduce their risk of developing ovarian cancer. Doctors in turn are recommended by the FDA to refer those at high risk of developing the disease to a gynecologic oncologist or genetic counselor.
Though there is no exact way to determine whether a woman will develop ovarian cancer, some factors are believed to increase the risk of cancer.
In general, aging puts a woman at increased risk of cancer and therefore elderly and middle-aged women are slightly prone to ovarian cancer. Women with a family history of ovarian cancer and those with BRCA1 or BRCA2 gene mutation are also at high risk of ovarian cancer.
Women that had melanoma, breast, cervical and colorectal cancer and those that had trouble conceiving or had never given birth are also at risk of ovarian cancer. Women from an Eastern European (Ashkenazi) Jewish background are also more likely to develop ovarian cancer compared to women from other ethnic groups. Women with endometriosis and those that had estrogen supplements without progesterone for 10 years or more may also have an elevated risk of ovarian cancer.
However, women should note that risk factors mean increased risk, and that having one or more of the factors doesn’t mean they would certainly have cancer. The CDC recommends that women talk to their doctors about their cancer risk.
Connie’s comments: My mom had hysterectomy (surgical removal of ovaries and uterus) because she got infected when her inner tissues was scratched by an IUD and had ectopic pregnancy as a result. My sister’s ovary was removed when she was in her 30s. When I was a nutritionist in the clinic of two surgeons who performed hysterectomies, I have seen lab results of women and most of them had parasites and had consumed dairy and birth control pills at an early age.
Know your genes
“Nutrition is very important,” Dr. Burzynski says. “One of the things, as we are alluding to with curcumin, is to control inflammation. That’s one of things you must do before you get cancer, and also when you have cancer.
Keeping your body with the proper nutrients is essential. We don’t want to “feed the cancer.” Things that promote cancer, we try to eliminate. We try to eliminate a lot of sugar. That for the most part will fuel the cancer growth.
We want to eliminate glutamine. Glutamine is an amino acid. It’s great if you want to be a bodybuilder or if you don’t have cancer, but if you do have cancer, for the most part, we encourage our patients to stay away from glutamine because that unfortunately is going to be one of the essential ingredients to cancer growth.”
… Certainly, the diet depends on the context of the medications we are using for the patient. Certain dietary ingredients are going to support the medications which we prescribe. Some others may neutralize it.
We have to take under consideration which medication we prescribe. And then make sure that the patient is not taking supplements or dietary ingredients that can fight these medications. This is also established for every patient.”
Impressive Success Rates
Dr. Burzynski currently has statistics for about 40 different types of cancer, covering close to 2,000 patients. Their oncology practice has an average of 50 to 60 percent success rate for either substantial decrease of the tumor sites or complete remission.
“But you have to understand that these are relatively recent medications. Many of these medications were introduced only about a year ago. For this group of patients, it’s too premature to have long term survival data because the medications are brand new.
On the other hand, if you are talking about the treatment with antineoplastons, for every clinical trial we have separate statistics. The best results were obtained in the treatment of astrocytoma. In clinical trials for astrocytoma… 67 percent of patients obtained objective response, which means the tumors disappeared completely, which is called complete response. (More than 50 percent decrease of tumor size is a partial response.)
The rest of the patients had stabilization of the disease. In this particular clinical trial, we did not have any patient who had progressive disease. Zero progressive disease for this particular trial.”
To put this into perspective, some of the best combination treatments you will currently find for the treatment of astrocytoma have a success rate of approximately 30-40 percent, and a progressive disease rate of about 40 percent, according to Dr. Burzynski.
Other Complementary Treatment Strategies
Two other components considered to be very important in alternative medicine in the treatment of cancer are exercise and the mind-body-spirit-stress connection.
Dr. Burzynski agrees that exercise is very important, and that your mind is indeed a powerful factor when addressing disease. In their practice, they use neurolinguistic programming to help their patients relax, and to promote a stress-free experience in their office.
“A lot of times people don’t have that stress free environment. This helps all their cells get better and with that, their stress is relieved and their blood pressure improves.
… And, as you mentioned exercise is huge. Patients should not be in bed. We need to get them moving. Studies have shown that exercise helps cancer patients across the board.”
On Harassment and Ignorance by the Conventional Medicine Community
By now many of you are probably thinking that since Dr. Burzynski is using genetics, the medical community must laud and support their efforts. Unfortunately, that’s not necessarily so.
Back in the 1990’s, the state of Texas tried to take away his medical license, claiming he was a fraud.
“This was based on complete lack of understanding and scientific ignorance,” Dr. Burzynski explains. “Obviously, the people who were persecuting us, most of them did not know what they were doing, but some of them knew very well because they were trying to steal my patents and my invention.
There was a combination of factors. You mentioned State authorities; this was one level of harassment. Another level of harassment was from the Federal government, represented by the FDA. Apparently… it was triggered by a pharmaceutical company, which together with the National Cancer Institute was trying to appropriate our patent. It was very convenient to persecute me and try to put me in prison.
However, they were not successful, we won.
It was extremely difficult to practice under such circumstances, but the clinic was open every day… It was very tough. I remember waking up early in the morning, coming to the clinic at 5 or 6 in the morning, seeing patients then going to court at 8 o’clock, spending the entire day in court until 5 pm, then coming back to the clinic, seeing patients, taking care of medical records well after midnight. This was day after day. It was an extremely difficult situation but we went through it, and we won.
At this moment, we have very good cooperation with FDA. We are working together and hopefully we will have successful phase 3 clinical trials.”
Amazingly, this legal fight dragged on for 14 years! It’s hard to imagine anyone making it through such an ordeal. Most people don’t. As for the cost, Dr. Burzynski describes it as “tremendous.” After factoring in the actual legal expenses and the lost revenue, the tally comes to about $3 million.
In addition, the FDA and Federal government allegedly spent about $60 million on the litigation alone—just to appropriate his patents for a pharmaceutical company! The pharmaceutical company in question eventually went bankrupt after Dr. Burzynski won the case. According to Dr. Burzynski, the full story will be detailed in an upcoming documentary.
Much of the resistance against alternative and complementary cancer strategies such as the protocol developed by Dr. Burzynski really flies in the face of common sense. Conventional medicine purports to be beholden to science-based medicine, yet it resists and denies solid science-based evidence again and again.
Still, pioneers such as Dr. Burzynski and his son keep moving forward; laying the groundwork for the inevitable paradigm shift.
“To sum it up, I think the 21st century is going to be known for personalized medicine and also preventing certain diseases in that sense,” Dr. Burzynski says. “I hope with all the tools we have, we’ll get really great results.”
–
Dr. Stanislaw Burzynski and his son, Dr. Gregory Burzynski, employ novel gene-target therapies in the treatment of cancer, which is the leading cause of death in the US.
Born in the early 1940’s in Poland, Dr. Stanislaw Burzynski was trained as a biochemist and a physician, and has been developing a treatment called antineoplastons over the past 35 years. He’s also the Founder, President and Chairman of the Burzynski Institute, located in both Houston, Texas, and Stafford
Reblogged this on Full of Life Community.
Reblogged this on Full of Life Community.